Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Armand

Showing results (91-100 of 273) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.
Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysisJoshua A Hill, Sophia Koo, Belisa B Guzman Suarez, et al.
Leukemia & Lymphoma|July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphomaEric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort AnalysisMahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Haematologica|June 30, 2016
A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantationSarah Nikiforow, Haesook T Kim, Heather Daley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantationJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
British Journal of Haematology|June 17, 2020
Pembrolizumab in relapsed or refractory Richter syndromePhilippe Armand, Niels Murawski, Daniel Molin, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
Pageof 28

Showing results (91-100 of 273) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.
Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysisJoshua A Hill, Sophia Koo, Belisa B Guzman Suarez, et al.
Leukemia & Lymphoma|July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphomaEric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort AnalysisMahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Haematologica|June 30, 2016
A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantationSarah Nikiforow, Haesook T Kim, Heather Daley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantationJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
British Journal of Haematology|June 17, 2020
Pembrolizumab in relapsed or refractory Richter syndromePhilippe Armand, Niels Murawski, Daniel Molin, et al.
The Oncologist|December 30, 2017
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and AnalysisLova Sun, Shuli Li, Areej El-Jawahri, et al.
Pageof 28